Abstract:OBJECTIVE:Methylmalonic aciduria is the most common disorder of organic acidurias in the mainland of China. It is also the one of treatable metabolic disorders. The clinical spectrum of the patients varies from severe neonatal-onset forms with neonatal brain injury and high mortality to milder forms with adult-onset. The clinical manifestations of neonates with methylmalonic aciduria are non-specific. Early diagnosis and adequate treatment contribute a lot to improving the prognosis of the patients. In this study, the abnormal clinical and laboratory findings in neonatal period of 160 Chinese patients with early-onset methylmalonic aciduria were investigated.METHOD:From 1996 to 2011, a total of 398 patients with methylmalonic aciduria were diagnosed in our hospital; 286 (71.9%) patients had early-onset before 1 year of age. Among 286 patients, 160 (55.9%) presented symptoms in neonatal period. Their urine organic acids were analyzed by gas chromatography-mass spectrometry. Blood amino acids and acylcarnitine profiles were determined by liquid chromatography tandem mass spectrometry. Serum and urine total homocysteine were measured using a fluorescence polarization immunoassay. In some patients, gene analysis was performed. Based on the disease types and general condition, individual dietary and medical interventions were started soon after diagnosis.RESULT:Out of the 160 patients, 131 (81.9%) had combined methylmalonic aciduria and homocysteinemia. Isolated methylmalonic aciduria was found in 29 cases (18.1%). The common presentations in neonatal period were feeding difficulty, seizures, lethargy and dyspnea. Megaloblastic anemia, liver dysfunction, hyperammonemia and metabolic acidosis were the frequent findings in the routine laboratory test. The most common initial clinical diagnosis was suspected hypoxic-ischemic encephalopathy. Even in 36 cases with abnormal family history, only 3 patients were admitted with suspected inborn errors of metabolism. Five cases (3.1%) were diagnosed by postmortem metabolic examination; 7 cases (4.4%) were detected by newborn screening. In 148 cases (92.5%), the diagnosis was much delayed to the age of one month to 8 years and 5 months (mean 13 months). Methylmalonic aciduria combined with homocysteinemia (MMACHC) gene analyses were performed in 31 cases with combined methylmalonic aciduria. CblC defect was confirmed. The patients with isolated methylmalonic aciduria were treated with protein-restricted diet, cobalamin and L-carnitine. The patients of methylmalonic aciduria combined with homocysteinemia were treated with cobalamin, L-carnitine, calcium folinate, betaine and common diet. Seven patients died without treatment. Clinical improvement was observed in 153 patients. Only 2 patients detected by newborn screening had normal mental and physical development. Mild to severe psychomotor retardation was observed in 151 cases.CONCLUSION:High mortality and disability rates were observed in the patients with early-onset methylmalonic aciduria. Combined methylmalonic aciduria and homocysteinemia is the common type of methylmalonic aciduria. The clinical manifestation in neonatal period of the patients with early-onset methylmalonic aciduria is complex. Feeding difficulty, seizures, lethargy and dyspnea are the common symptoms in neonatal period of the patients. Megaloblastic anemia, liver dysfunction, hyperammonemia and metabolic acidosis were the frequent laboratory findings.

Diseases Spectrum of Metabolism Disease of Amino Acid, Organic Acid and Fatty Acid Oxidation in Neonates

[Screening for Fatty Acid Oxidation Disorders of Newborns in Zhejiang Province:Prevalence, Outcome and Follow-Up].

[Screening for Newborn Organic Aciduria in Zhejiang Province:Prevalence, Outcome and Follow-Up].

[Disease Spectrum Analysis of Children with Inherited Metabolic Diseases Detected by Gas Chromatography-Mass Spectrometry of Urinary Organic Acids].

Spectrum analysis of common inherited metabolic diseases in Chinese patients screened and diagnosed by tandem mass spectrometry.

[Screening for neonatal inborn errors of metabolism by electrospray ionization-tandem mass spectrometry and follow-up].

Current Problems and Prospect on Tandem Mass Spectrometry Based Newborn Inherited Metabolic Diseases Screening

Etiological Spectrum and Clinical Characteristics of Neonates with High Risk of Inborn Errors of Metabolism: A Five-year Retrospective Analysis

[Genetic Analysis of Newborns with Abnormal Metabolism of 3-Hydroxyisovalerylcarnitine].

Variations of Amino Acid, Free Carnitine and Acylarnitine Profiles Analysed by Tandem Mass Spectrometry in Newborns During Their First Four Weeks of Life

[Analysis of disease spectrum for abnormal 3-hydroxyisovalerylcarnitine metabolism identified through newborn screening and clinical diagnosis].

[Diagnosis of Inborn Errors of Metabolism Using Tandem Mass Spectrometry and Gas Chromatography Mass Spectrometry].

A Multi-Center Study of Biochemical and Hotspot Gene Screening for Neonatal Genetic Metabolic Diseases

A Disease Spectrum Analysis of 564 Cases of Inherited Metabolic Diseases Tested by Gas Chromatography-Mass Spectrometry

Treatment and prognosis of developmental delay in children caused by inborn errors of metabolism

Clinical Analysis of 14 Cases of Neonatal Organic Aciduria

Analysis of Impaired Nervous System and Symptoms in 81 Children with Inherited Metabolic Disorders

Study of application of the tandem mass spectrometry in the differential diagnosis of organic acidemias

[Abnormal Findings During Newborn Period of 160 Patients with Early-Onset Methylmalonic Aciduria].

Spectrum Analysis of Inherited Metabolic Disorders for Expanded Newborn Screening in a Central Chinese Population

Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan